+91-22-45045900 sales@clearsynth.com
Therapeutic Product Detail
Home Therapeutic Tofacitinib CS-T-62103

(3R,4S)-Tofacitinib

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-62103 Therapeutic Research Use Only
(3R,4S)-Tofacitinib
Category
Therapeutic
API Family
Tofacitinib
Product Code
CS-T-62103
Research Status
For Laboratory Use

(3R,4S)-Tofacitinib

Tofacitinib Therapeutic
Stock Status: In Stock
Live

CAT No.
CS-T-62103
CAS No.
1092578-46-5
Molecular Formula
C₁₆H₂₀N₆O
Molecular Weight
312.37
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1092578-46-5
Product Code
CS-T-62103
M.F.
C₁₆H₂₀N₆O
M.W.
312.37
Category
Therapeutic
API Family
Tofacitinib
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
References
Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)
Synonyms
Not available,
Application Notes
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.

Customers Also Viewed

Tofacitinib impurity I

Tofacitinib impurity I

CAT No: CS-AQ-00038
CAS No: NA
Tofacitinib Related Compound 29

Tofacitinib Related Compound 29

CAT No: CS-EO-01845
CAS No: 134965-85-8
Tofacitinib Impurity 6

Tofacitinib Impurity 6

CAT No: CS-EO-01450
CAS No: 2504210-38-0
Tofacitinib N-hydroxy impurity

Tofacitinib N-hydroxy impurity

CAT No: CS-EO-00807
CAS No: NA
Tofacitinib Impurity 67

Tofacitinib Impurity 67

CAT No: CS-O-57488
CAS No: 2716897-35-5
Tofacitinib Nitroso Impurity 4

Tofacitinib Nitroso Impurity 4

CAT No: CS-O-45595
CAS No: NA
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide

N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide

CAT No: CS-O-45589
CAS No: NA
Tofacitinib Amine intermediate

Tofacitinib Amine intermediate

CAT No: CS-O-32365
CAS No: 477600-74-1
N,4-dimethyl-1-nitrosopiperidin-3-amine

N,4-dimethyl-1-nitrosopiperidin-3-amine

CAT No: CS-O-45597
CAS No: NA
N-Nitroso Tofacitinib Amine Impurity D4

N-Nitroso Tofacitinib Amine Impurity D4

CAT No: CS-O-53679

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.